Brief: Vericel Corp Sees FY Revenue Of About $164.0 Mln To $165.0 Mln

Vericel

10/01/2023 13:02

Jan 10 (Reuters) - Vericel Corp  VCEL.O :
    * SEES FY REVENUE ABOUT $164.0 MILLION TO $165.0 MILLION
    * MACI ARTHROSCOPIC COMMERCIAL LAUNCH NOW PLANNED FOR 2024
    * AS OF DECEMBER 31, 2022, CO HAD ABOUT $140 MILLION IN CASH
AND
INVESTMENTS AND NO DEBT
    * EXPECT TO HOLD A PRE-IND MEETING WITH FDA IN FIRST HALF OF
2023
TO DISCUSS MACI DEVELOPMENT PROGRAM
    * FY2022 REVENUE VIEW $164.6 MILLION -- REFINITIV IBES DATA
    * NOW ANTICIPATES AN ACCELERATED POTENTIAL COMMERCIAL LAUNCH
OF
ARTHROSCOPIC MACI IN 2024

Source text for Eikon:  ID:nGNX8PtyMS 
Further company coverage:  VCEL.O 
 ((reuters.briefs@thomsonreuters.com;))